Related Experiment Video
Updated: Jul 2, 2026
06:47
Microfluidics in Assessing Platelet Function
Published on: November 8, 2024
Circulating microparticles from patients with septic shock exert protective role in vascular function
Hadj Ahmed Mostefai1, Ferhat Meziani, Maria Letizia Mastronardi
1INSERM U771, CNRS UMR 6214, and Université d'Angers, France.
American Journal of Respiratory and Critical Care Medicine
|August 30, 2008
Summary
Increased microparticles in septic shock patients enhance aortic contraction via thromboxane A2, suggesting a protective role against vascular hyporeactivity and hypotension.
Area of Science:
- Cardiovascular Research
- Inflammation and Immunology
- Sepsis Pathophysiology
Background:
- Sepsis involves complex interactions between inflammation and coagulation.
- Activated circulating and vascular cells release microparticles, key mediators in sepsis.
Purpose of the Study:
- Characterize circulating microparticles in septic shock patients versus nonseptic individuals.
- Evaluate the impact of these microparticles on vascular function.
Main Methods:
- Flow cytometry analyzed microparticles and their cellular origins in septic shock patients and controls.
- Microparticles were administered to mice to assess aortic vascular reactivity.
- Enzyme activity related to nitric oxide (NO) and cyclooxygenase pathways was analyzed.
Main Results:
- Septic shock patients exhibited elevated levels of circulating microparticles, particularly those derived from platelets and endothelial cells.
- Septic microparticles paradoxically enhanced aortic contraction sensitivity to serotonin in mice.
- This effect was mediated by increased thromboxane A2 production, not by NO or calcium signaling pathways.
Conclusions:
- Elevated circulating microparticles in sepsis are associated with enhanced thromboxane A2 production.
- These microparticles appear to counteract vascular hyporeactivity, potentially protecting against septic shock-induced hypotension.
